Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with PGD2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ehara H | [An experimental study on antitumor effect of prostaglandin D2]. | 1989 | Nihon Geka Gakkai Zasshi | pmid:2796985 |
Fukuda T | [Trend in chemical mediator research in asthma and its application for asthma treatment]. | 2003 | Nihon Kokyuki Gakkai Zasshi | pmid:14531291 |
Hoshi A et al. | [Experimental study on the role of prostaglandin D2 in the pathogenesis of bronchial asthma]. | 1992 | Nihon Kyobu Shikkan Gakkai Zasshi | pmid:1507684 |
Yamada K | [The effect of prostaglandin D2 on rat testicular testosterone levels]. | 1989 | Nihon Naibunpi Gakkai Zasshi | pmid:2591605 |
Suzuki H et al. | [Inhibition of growth of human endometrial adenocarcinoma cells in vitro treated with prostaglandin F2 alpha, E2, D2 and J2]. | 1986 | Nihon Naibunpi Gakkai Zasshi | pmid:3465609 |
Kudo M et al. | [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells]. | 1990 | Nihon Naibunpi Gakkai Zasshi | pmid:1962750 |
Fujitani Y et al. | [Sleep-promoting substances]. | 1998 | Nihon Ronen Igakkai Zasshi | pmid:10064966 |
Shimojima T et al. | [Effects of prostaglandins on superoxide production by human polymorphonuclear leukocytes]. | 1987 | Nihon Shishubyo Gakkai Kaishi | pmid:2851629 |
Goto H | [Quantitative determination of prostaglandin D2 in the rat gastric mucosa by high performance liquid chromatography]. | 1987 | Nihon Shokakibyo Gakkai Zasshi | pmid:3473244 |
Shiroma T et al. | [Production and metabolism of prostaglandin D2 by cultured chick retinal pigment epithelial cells]. | 1996 | Nippon Ganka Gakkai Zasshi | pmid:8741332 |
Mezawa A | [Nasal response to chemical mediators in nasal allergy]. | 1988 | Nippon Jibiinkoka Gakkai Kaiho | pmid:3199260 |
Wong P et al. | Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. | 1985 | Nippon Ketsueki Gakkai Zasshi | pmid:3890456 |
Kariya T et al. | Platelet abnormality with no response to PGD2 in a patient with metastatic pancreas carcinoma and myeloproliferative disorder. | 1987 | Nippon Ketsueki Gakkai Zasshi | pmid:3473883 |
Masuko-Hongo K | [Role of prostaglandins in rheumatoid arthritis]. | 2005 | Nippon Rinsho | pmid:15799333 |
Makino S | [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. | 1985 | Nippon Rinsho | pmid:2989584 |
Uehara Y | [Prostaglandin D2]. | 1999 | Nippon Rinsho | pmid:10635955 |
Uehara Y | [Prostaglandin D2 and related substances]. | 2010 | Nippon Rinsho | pmid:20960740 |
Fukushima S et al. | [Pharmaceutical and pharmacological development of antitumor prostaglandins]. | 1998 | Nippon Rinsho | pmid:9549353 |
Uehara Y | [Prostaglandin D2]. | 2005 | Nippon Rinsho | pmid:16149440 |
Hayaishi O | [Prostaglandins and sleep]. | 1998 | Nippon Rinsho | pmid:9503823 |
Urade Y | [Gene engineering studies on sleep]. | 1998 | Nippon Rinsho | pmid:9503856 |
Uchizono K | [Studies of sleep inducing substance]. | 1984 | Nippon Rinsho | pmid:6384575 |
Urade Y | [Molecular mechanisms of insomnia]. | 2009 | Nippon Rinsho | pmid:19768929 |
Saito H | [Mast cells]. | 2005 | Nippon Rinsho | pmid:15861652 |
Fukushima M | [Prostaglandin J2--anti-tumor activity and mechanism of action]. | 1988 | Nippon Rinsho | pmid:3043050 |
Nagata N and Urade Y | [Endogenous sleep-promoting substance]. | 2012 | Nippon Rinsho | pmid:22844810 |
Kikuchi Y et al. | [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. | 1990 | Nippon Sanka Fujinka Gakkai Zasshi | pmid:2313142 |
Kikuchi Y et al. | Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro. | 1987 | Nippon Sanka Fujinka Gakkai Zasshi | pmid:3479504 |
Hirai H | [Prostaglandin D2 in allergy: PGD2 has dual receptor systems]. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695454 |
Uehara Y | [PGD(2)/L-PGDS system in hypertension and renal injury]. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695455 |
Miwa Y et al. | Physiology and pharmacology of the prostaglandin J2 family. | 2004 | Nippon Yakurigaku Zasshi | pmid:14695456 |
Arai I | [Role of cutaneous prostaglandin D2 production on scratching dermatitis in mice]. | 2006 | Nippon Yakurigaku Zasshi | pmid:17167214 |
Tanaka H and Nagai H | [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation]. | 2001 | Nippon Yakurigaku Zasshi | pmid:11338375 |
Tsukagoshi H and Kurosawa M | [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. | 1992 | Nippon Yakurigaku Zasshi | pmid:1559641 |
Urade Y | [New aspects on prostaglandin D synthases]. | 1997 | Nippon Yakurigaku Zasshi | pmid:9503406 |
Ushikubi F and Narumiya S | [The roles of the prostanoids played in the body]. | 2002 | Nippon Yakurigaku Zasshi | pmid:11979724 |
Sonoki H et al. | [Effects of 3,4-diaminopyridine on the contractions of guinea-pig tracheal smooth muscle induced by histamine and prostaglandin D2]. | 1988 | Nippon Yakurigaku Zasshi | pmid:3163668 |
Onoe H | [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. | 1998 | Nippon Yakurigaku Zasshi | pmid:10202759 |
Satoh T | [Neurotrophin-like low molecular weight compounds]. | 2002 | Nippon Yakurigaku Zasshi | pmid:12491808 |
González E et al. | Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. | 2002 | Nitric Oxide | pmid:11890746 |
Takeshima Y | [Development of novel therapeutic approaches for Duchenne muscular dystrophy]. | 2014 | No To Hattatsu | pmid:24738186 |
Urade Y and Mohri I | [Sleep and brain function]. | 2006 | No To Hattatsu | pmid:16986732 |
Nakamura O et al. | [Antineoplastic effect of prostaglandins on human glioma in athymic nude mice]. | 1988 | No To Shinkei | pmid:3179087 |
Urade Y and Eguchi N | [Sleep substances]. | 2003 | No To Shinkei | pmid:12649899 |
Marone G et al. | The human heart as a shock organ in anaphylaxis. | 2004 | Novartis Found. Symp. | pmid:15025396 |
Corren J et al. | Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. | 2008 | Nutr J | pmid:18625073 |
Fajas L et al. | PPAR gamma: an essential role in metabolic control. | 2001 | Nutr Metab Cardiovasc Dis | pmid:11383325 |
Juman S et al. | Effects of long-term oral administration of arachidonic acid and docosahexaenoic acid on the immune functions of young rats. | 2013 | Nutrients | pmid:23760060 |
Schäffler A et al. | Regulation and function of collagenous repeat containing sequence of 26-kDa protein gene product "cartonectin". | 2007 | Obesity (Silver Spring) | pmid:17299102 |
Menon R et al. | Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. | 2011 | Obstet Gynecol | pmid:21691170 |
Norwitz ER et al. | Prostaglandin D2 production by term human decidua: cellular origins defined using flow cytometry. | 1992 | Obstet Gynecol | pmid:1495703 |
Burgermeister E et al. | Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. | 2003 | Oncogene | pmid:12813462 |
Kar R et al. | A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. | 2009 | Oncogene | pmid:19448671 |
Kim DH et al. | 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. | 2010 | Oncogene | pmid:20208557 |
Crabb SJ et al. | BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. | 2008 | Oncol. Rep. | pmid:18288403 |
Takashima T et al. | Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. | 2005 | Oncol. Rep. | pmid:15756430 |
Servidei T et al. | The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines. | 2004 | Oncol. Res. | pmid:15301425 |
Walther U et al. | Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway. | 2016 | Oncotarget | pmid:26863638 |
Yen CC et al. | Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. | 2014 | Oncotarget | pmid:24566468 |
Yuan J et al. | M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway. | 2017 | Oncotarget | pmid:28423639 |
Ogino N et al. | Phagocytic activity of cultured retinal pigment epithelial cells from chick embryo: inhibition by melatonin and cyclic AMP, and its reversal by taurine and cyclic GMP. | 1983 | Ophthalmic Res. | pmid:6136017 |
Woodward DF et al. | Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. | 1989 | Ophthalmic Res. | pmid:2626239 |
Huisingh C and McGwin G | Change in prostaglandin expression levels and synthesizing activities. | 2013 | Ophthalmology | pmid:24001535 |
Rim TH et al. | Author reply: To PMID 22858125. | 2013 | Ophthalmology | pmid:24001536 |
Shim J et al. | Change in prostaglandin expression levels and synthesizing activities in dry eye disease. | 2012 | Ophthalmology | pmid:22858125 |
Sheddan NA and Mulzer J | Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. | 2006 | Org. Lett. | pmid:16805562 |
Brummond KM et al. | The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry. | 2004 | Org. Lett. | pmid:14723515 |
Blázovics A et al. | [Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases]. | 2004 | Orv Hetil | pmid:15662752 |
Fahmi H et al. | Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1. | 2002 | Osteoarthr. Cartil. | pmid:11869069 |
Fahmi H et al. | 15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. | 2002 | Osteoarthr. Cartil. | pmid:12435328 |
Ebersberger A et al. | Effects of prostaglandin D2 on tetrodotoxin-resistant Na+ currents in DRG neurons of adult rat. | 2011 | Pain | pmid:21345590 |
Minami T et al. | Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. | 1994 | Pain | pmid:7916452 |
Masamune A et al. | Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. | 2002 | Pancreas | pmid:11854617 |
Hashimoto K et al. | Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. | 2004 | Pancreas | pmid:15028947 |
Hashimoto K et al. | The PPARgamma ligand, 15d-PGJ2, attenuates the severity of cerulein-induced acute pancreatitis. | 2003 | Pancreas | pmid:12826907 |
Closa D et al. | Prostaglandin D2, F2 alpha, E2, and E1 in early phase of experimental acute necrohemorrhagic pancreatitis in rats. | 1994 | Pancreas | pmid:7509066 |
Wang Y et al. | Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. | 2009 | Pediatr. Res. | pmid:19262292 |
Uemura S et al. | Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. | 1984 | Pediatr. Res. | pmid:6596550 |
Zhao H et al. | Met-Arg-Trp derived from Rubisco lowers blood pressure via prostaglandin D(2)-dependent vasorelaxation in spontaneously hypertensive rats. | 2008 | Peptides | pmid:18180074 |
Bai G et al. | Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2. | 2009 | Peptides | pmid:19539681 |
Zhao H et al. | Rubimetide (Met-Arg-Trp) derived from Rubisco exhibits anxiolytic-like activity via the DP1 receptor in male ddY mice. | 2008 | Peptides | pmid:18243414 |
Shimatsu A et al. | Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood. | 1984 Mar-Apr | Peptides | pmid:6591147 |
Peeraully MR et al. | Prostaglandin D2 and J2-series (PGJ2, Delta12-PGJ2) prostaglandins stimulate IL-6 and MCP-1, but inhibit leptin, expression and secretion by 3T3-L1 adipocytes. | 2006 | Pflugers Arch. | pmid:16924534 |
Bhattacharya SK and Parmar SS | Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism. | 1987 | Pharm. Res. | pmid:2977646 |
Hagens WI et al. | Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. | 2007 | Pharm. Res. | pmid:17245650 |
Eichele K et al. | R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. | 2009 | Pharm. Res. | pmid:19015962 |
Csányi G et al. | Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. | 2008 May-Jun | Pharmacol Rep | pmid:18622059 |
Saito R et al. | The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats. | 1987 | Pharmacol. Biochem. Behav. | pmid:2883669 |
Hollingsworth EB and Patrick GA | The effects produced by prostaglandin D2 on serotonin turnover and release and tryptophan uptake. | 1985 | Pharmacol. Biochem. Behav. | pmid:2581275 |
Nielsen JA and Sparber SB | Central administration of prostaglandin E2 facilitates while F2 alpha attenuates acute dependence upon morphine rats. | 1985 | Pharmacol. Biochem. Behav. | pmid:3860881 |
Hollingsworth EB and Patrick GA | Involvement of the serotonergic system in the prolongation of pentobarbital sleeping time produced by prostaglandin D2. | 1985 | Pharmacol. Biochem. Behav. | pmid:2859604 |
D'Onofrio C et al. | The antiproliferative effect of prostaglandin A and J on HTLV-I transformed cells is associated with induction of a heat-shock protein. | 1990 Sep-Oct | Pharmacol. Res. | pmid:2284244 |
Reyes-Martin P et al. | Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. | 2007 | Pharmacol. Res. | pmid:17291778 |
Reyes-Martin P et al. | 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. | 2008 | Pharmacol. Res. | pmid:18456507 |
Schuligoi R et al. | CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases. | 2010 | Pharmacology | pmid:20559016 |
Prenn C et al. | CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine. | 2008 | Pharmacology | pmid:18212515 |
Tanaka H et al. | Possible involvement of prostaglandins F(2alpha) and D(2) in acetylcholine-induced positive inotropy in isolated mouse left atria. | 2003 | Pharmacology | pmid:12571412 |
Azuma Y et al. | Induction of proliferation by 15-deoxy-delta12,14-prostaglandin J2 and the precursors in monocytic leukemia U937. | 2004 | Pharmacology | pmid:15240994 |
Hayaishi O | Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. | 2000 | Philos. Trans. R. Soc. Lond., B, Biol. Sci. | pmid:10724461 |
Murphy PJ et al. | Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. | 1994 | Physiol. Behav. | pmid:8047572 |